Karte und Zugangsinformationen
Öffentlicher Nahverkehr (ÖPNV)
- U-Bahn - U Alt-Tegel (Linie U6)
- Bus - U Alt-Tegel (Linien 125, 124, 222, 220 und 133)
- Bus - Tegel-Center (Linien 222, 133, 124, 220 und 125)
Zugangsinformationen
- 1.OG mit Fahrstuhl
- Barrierefreier Zugang
Profil
Website
Website öffnenVeröffentlichungen
Binder, D., Hegenbarth, K. Emerging - options for the management of non-small cell lung cancer. Clin Med Insights Oncol.
Binder, D., Buckendahl AC, Hübner RH, Schlattmann P, Temmesfeld-Wollbrück B, Beinert T, Suttorp N. - Erlotinib in patients with advanced non-small-cell lung cancer: impact of dose reductions and a novel surrogate marker. Med Oncol.
Binder, D., Hübner RH, Temmesfeld-Wollbrück B, Schlattmann P. - Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials. Cancer Chemother Pharmacol.
Agaylan A, Binder, D., Sauer M, Neuweiler H, Meyer O, Kiesewetter H, Salama A. - A highly sensitive particle agglutination assay for the detection of P53 autoantibodies in patients with lung cancer.